Interview: The national institute of neurological diseases and stroke/American epilepsy society benchmarks and research priorities for epilepsy research

Biomarkers in Medicine

Volumn 5, Issue 5, 2011, Pages 531-535

  Lowenstein, Daniel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BRAIN DEPTH STIMULATION; BRAIN INFECTION; BRAIN TUMOR; COMORBIDITY; DISEASE COURSE; ENCEPHALITIS; EPILEPSY; FOLLOW UP; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MENTAL DISEASE; NEUROLOGIC DISEASE; NOTE; QUALITY CONTROL; REMISSION; STROKE; TRAUMATIC BRAIN INJURY;

BENCHMARKING; BIOLOGICAL MARKERS; EPILEPSY; GENOMICS; HUMANS; RESEARCH;

EID: 80054818419     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.69     Document Type: Note

References (18)

1. Kelley MS, Jacobs MP, Lowenstein DH; NINDS Epilepsy Benchmark Stewards. The NINDS epilepsy research benchmarks. Epilepsia 50(3), 579-582 (2009).
2. Engel J Jr. Biomarkers in epilepsy: introduction. Biomarkers Med. 5(5), 537-544 (2011).
3. Helbig I, Scheffer IE, Mulley JC, Berkovic SF. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol. 7(3), 231-245 (2008). (Pubitemid 351215982)
4. Sisodiya SM, Mefford HC. Genetic contribution to common epilepsies. Curr. Opin. Neurol. 24(2), 140-145 (2011).
5. Poduri A, Lowenstein D. Epilepsy genetics - past, present, and future. Curr. Opin. Genet. Dev. 21(3), 325-332 (2011).
6. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat. Rev. Neurol. 7(1), 31-40 (2011).
7. Kharatishvili I, Pitkanen A. Posttraumatic epilepsy. Curr. Opin. Neurol. 23(2), 183-188 (2010).
8. Stafstrom CE, Arnason BG, Baram TZ, et al. Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J. Child Neurol. DOI: 10.1177/0883073811413129 (2011) (Epub ahead of print).
9. Wong M. Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications. Epilepsia 50(Suppl. 9), 34-44 (2009).
10. Bragin A, Engel J Jr, Staba RJ. High-frequency oscillations in epileptic brain. Curr. Opin. Neurol. 23(2),151-156 (2010).
11. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens- Johnson syndrome. Nature 428(6982), 486 (2004).
12. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51(5), 899-908 (2010).
13. Smith JR, Fountas KN, Murro AM, et al. Closed-loop stimulation in the control of focal epilepsy of insular origin. Stereotact. Funct. Neurosurg. 88(5), 281-287 (2010).
14. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology 58(6), 855-864 (2010).
15. Hirsch LJ, Donner EJ, So EL, et al. Abbreviated report of the NIH/NINDS workshop on sudden unexpected death in epilepsy. Neurology 76(22), 1932-1938 (2011).
16. National Institute of Neurological Diseases and Stroke (NINDS). Curing epilepsy: the promise of research www.ninds.nih.gov/disorders/epilepsy/ epilepsy-research.htm#Appendix).
17. Epilepsy Phenome/Genome Project (EPGP) www.epgp.org/Pages/Default.aspx).
18. National Institute of Neurological Diseases and Stroke (NINDS). Epilepsy centers without walls www.ninds.nih.gov/research/epilepsyweb/ feedback.htm).